Mascoma Wealth Management LLC Rubius Therapeutics, Inc. Transaction History

Mascoma Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	BUY	$0.79 - $5.98 $592 - $4,485	750 Added 300.0%	1,000 $1,000
Q4 2021 Jan 21, 2022	BUY	$9.68 - $17.74 $1,452 - $2,660	150 Added 150.0%	250 $2,000
Q3 2021 Oct 06, 2021	BUY	$17.6 - $25.91 $1,760 - $2,591	100 New	100 $2,000
Q2 2021 Jul 06, 2021	SELL	$22.26 - $28.43 $2,226 - $2,843	-100 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$8.02 - $32.01 $802 - $3,201	100 New	100 $2,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Mascoma Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mascoma Wealth Management LLC with notifications on news.